We show that DNAJB6 modifies the toxicity and solubility of multiple amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD)-linked RNA-binding proteins (RBPs). This evidence concerns the gene DNAJB6 and amyotrophic lateral sclerosis.